United States
Dr. Spencer Nadolsky is a board-certified obesity medicine and lipidology physician who has built a substantial social media presence by translating complex metabolic science — particularly around GLP-1 receptor agonists like semaglutide and tirzepatide — into accessible, often meme-driven content.
Total Followers +2.3%
532K
Across YouTube, Instagram
Primary Platform
YouTube
54K followers · 10% of audience
Engagement
5.8%
vs. 1.5% category median
Sponsorship Tier
Mid
Est. $7.2K–$17K / IG post
After departing as Medical Director at WeightWatchers (September 2024), Nadolsky founded Vineyard — a self-funded, physician-led telehealth practice offering brand-name GLP-1 medications, dietitian support, and his LiftRx strength program, now open across all 50 states.
Nadolsky publicly noted Vineyard's goal to conduct decentralized clinical trials studying how GLP-1 medications, exercise, and high-protein diets affect body composition — positioning the clinic as an active research organization, not just a care provider.
| Window | YouTube | Combined | ||
|---|---|---|---|---|
| Last 7 days | +1K +2.3% | +862 +0.2% | +0 +0.0% | +2K |
| Last 30 days | +7K +12.8% | +5K +1.1% | +0 +0.0% | +12K |
| Last 90 days | +42K +77.8% | +18K +3.8% | +0 +0.0% | +60K |
| Last 365 days | +42K +77.8% | +18K +3.8% | +0 +0.0% | +60K |
Daily follower snapshots from CreatorDB's longitudinal index.
| Brand | Type | Platform | Date | Performance vs. baseline |
|---|---|---|---|---|
| Vineyard (joinvineyard) Telehealth / GLP-1 Care | Founder / owned brand | Long-term | — | |
| Chef Rx (chefrx.co) Nutrition / Food | Founder / owned brand | Long-term | — |
Dr. Spencer Nadolsky is a board-certified obesity medicine and lipidology physician who has built a substantial social media presence by translating complex metabolic science — particularly around GLP-1 receptor agonists like semaglutide and tirzepatide — into accessible, often meme-driven content. His self-designation as a 'Meme Specialist Doc' signals the deliberate tonal contrast he strikes: clinical credibility wrapped in irreverence. As co-host of the Docs Who Lift podcast, Nadolsky operates at the intersection of evidence-based medicine and fitness culture, a niche that keeps his commentary grounded in practical application rather than pure theory. His YouTube channel, though smaller than his Instagram footprint, has seen notable acceleration, suggesting an audience actively seeking long-form explainers on emerging obesity pharmacology and maintenance protocols.
Nadolsky's audience skews toward adults over 35, with a majority female readership — a demographic profile that aligns closely with the primary users of GLP-1 therapies in the United States, where the vast majority of his followers are based. Beyond content creation, he has extended into entrepreneurship through Vineyard, a direct-care or telehealth platform, and ChefRx, a food-and-nutrition concept — moves that position him less as a pure influencer and more as a practitioner-entrepreneur with recurring touchpoints in the patient journey. His engagement rate, running well above category median, reflects an audience that treats his content as a trusted reference rather than passive entertainment. As GLP-1 medications continue to reshape obesity treatment and attract intense media scrutiny, Nadolsky's dual standing as a prescribing clinician and high-volume content creator gives him durable relevance with both consumer health brands and pharmaceutical-adjacent partners.
Drnadolsky reaches an audience concentrated in United States primarily through YouTube, and is best activated via long-form YouTube integrations, Instagram Reels and Stories. Their sponsorship history skews toward Telehealth / GLP-1 Care, Nutrition / Food, a clear signal of fit for brands in those categories. Demonstrated partners include Vineyard (joinvineyard) and Chef Rx (chefrx.co). Engagement on YouTube runs around 5.8%, which points to an audience better suited to category-relevant, mid-funnel campaigns than to pure-reach buys. The channel's mix of long-form YouTube integrations and Instagram Reels and Stories lets a sponsor choose between short awareness placements and longer, more detailed integrations. Because the audience follows health content rather than arriving through untargeted reach, sponsorships that match the channel's subject matter tend to convert more efficiently than broad placements. A consistent, on-topic posting focus gives sponsors a predictable, brand-safe environment, lowering placement risk compared with broad, general-interest channels. Campaigns here are best measured on qualified engagement and consideration within the niche rather than on raw impression volume. For United States-focused brands in Telehealth / GLP-1 Care and related categories, Drnadolsky offers a defined, creative-fit audience rather than broad, low-intent impressions.
Benchmark estimates for a creator at Drnadolsky's tier (Mid, 532K combined followers, United States). Pulled from CreatorDB's category benchmarks.
The CreatorDB Agency runs end-to-end influencer campaigns globally — shortlisting, outreach, contracting, and performance reporting. Talk to our team about building a campaign around creators in this niche.
Dr. Nadolsky is a board-certified obesity medicine and lipid specialist physician based in the United States. He focuses on evidence-based treatment of obesity and cholesterol disorders, including newer medications like GLP-1 receptor agonists such as semaglutide and tirzepatide.
Yes — Spencer Nadolsky is his full name, which he uses in his own hashtags and professional profiles. He goes by @drnadolsky on social media, but Spencer Nadolsky is the name attached to his medical credentials and publications.
Docs Who Lift is a podcast co-hosted by Dr. Nadolsky where physicians discuss medicine, fitness, and weight management in a candid, no-nonsense format. The name reflects the hosts' identity as practicing doctors who also prioritize strength training and physical health in their own lives.
Vineyard (joinvineyard) is a company Dr. Nadolsky founded, which he links directly in his Instagram bio alongside the call to 'get GLP-1 expert care.' It appears to be a platform connecting patients with specialized obesity medicine practitioners, including access to medications like semaglutide and tirzepatide.
Chef Rx (chefrx.co) is a brand Dr. Nadolsky founded — the name blends 'chef' (food) and 'Rx' (prescription/medicine). Based on his overarching focus on obesity medicine, it appears to address the nutrition and meal-planning side of weight management, complementing the medication-focused care he promotes through his other venture, Vineyard.
One of Dr. Nadolsky's most prominent videos is titled 'Most People Get GLP-1 Wrong: Here's What Works,' reflecting his repeated message that patients and clinicians often misunderstand proper dosing, side-effect management, and long-term expectations. He argues that what happens after you start — and especially after you stop — a GLP-1 is a conversation the broader media almost never has honestly.
Dr. Nadolsky has dedicated content specifically to what he calls 'the truth about GLP-1 maintenance,' arguing it is the most under-discussed part of these medications. His position is that stopping semaglutide or tirzepatide without a structured plan typically leads to significant weight regain, and that long-term strategy needs to be built into treatment from the beginning.
Food noise is a term for the relentless, intrusive thoughts about food that many people with obesity experience, and GLP-1 medications like semaglutide are widely reported to dramatically reduce it. Dr. Nadolsky uses this term frequently because it helps his audience understand a psychological dimension of how these drugs work — beyond simple calorie suppression.
Retatrutide is a next-generation triple receptor agonist targeting GIP, GLP-1, and glucagon receptors that showed striking weight-loss results in early clinical trials. Dr. Nadolsky has covered emerging data on it directly, describing it as a topic that 'needs to be talked about,' signaling he sees it as a potentially significant advance beyond current GLP-1 options.
Dr. Nadolsky deliberately leans into humor and internet memes as a way to make serious topics — obesity stigma, Big Pharma criticism, GLP-1 side effects — feel less like a medical lecture and more like a conversation. Listing 'Meme Specialist' directly alongside 'Obesity/Lipid Specialist Doc' in his bio is a self-aware signal that he uses entertainment as a gateway into evidence-based medicine.
Stats (followers, engagement, audience demographics, growth) are pulled live from the CreatorDB API covering YouTube, Instagram and TikTok. Bio and FAQ content is AI-assisted; news items are sourced from cited public press at generation time. Read the full methodology →
If you'd like to update, correct, or remove this profile, get in touch and we'll handle it within 5 business days. We don't publish private data — every stat shown comes from your public platform profiles.
@drnadolsky · YouTube
+0 new followers
Preparing fresh data…
This usually takes 15–25 seconds.